Bliss GVS Pharma Limited share price
NSE: BLISSGVS · ISIN INE416D01022
Key numbers
- Market cap
- ₹ 7,493 Cr
- Current price
- ₹ 704.70
- 52-week high / low
- ₹ 728 / 118
- Stock P/E
- 55.9
- Book value
- ₹ 112.8
- Dividend yield
- 0.28%
- ROCE
- 16.4%
- ROE
- 11.5%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- 7.2%
- Profit growth (3 yrs)
- 22.1%
- 1-year return
- 365.0%
About Bliss GVS Pharma Limited
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 207 | 244 | 218 | 257 | 286 |
| Operating profit | 41 | 32 | 35 | 44 | 76 |
| Net profit | 43 | 27 | 23 | 36 | 50 |
| EPS (₹) | 4.08 | 2.58 | 2.20 | 3.27 | 4.73 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.